[肝硬化的利尿剂抵抗：药物治疗方法] - Suppr

Suppr

超能文献

[Diuretic resistance of liver cirrhosis: pharmacologic treatment approaches].

作者信息

Gross P, Wichmann A, Sieg A

机构信息

Klinikum Steglitz, Freie Universität Berlin, FRG.

出版信息

Klin Wochenschr. 1989 Aug 1;67(15):790-2. doi: 10.1007/BF01745352.

DOI:10.1007/BF01745352

PMID:2671479

Abstract

摘要

相似文献

[Diuretic resistance of liver cirrhosis: pharmacologic treatment approaches].[肝硬化的利尿剂抵抗：药物治疗方法]

Klin Wochenschr. 1989 Aug 1;67(15):790-2. doi: 10.1007/BF01745352.

Prevention of diuretic-induced electrolyte disturbances by amiloride in patients with ascites due to cirrhosis of the liver.

Acta Cardiol. 1973:Suppl 17:307-1.

Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites.利福昔明可改善酒精性肝硬化和腹水患者的全身血液动力学和肾功能。

Clin Gastroenterol Hepatol. 2012 Jul;10(7):815-8. doi: 10.1016/j.cgh.2012.02.025. Epub 2012 Mar 3.

Infusion of atrial natriuretic peptide in liver cirrhosis with ascites.

Lancet. 1985;2(8469-70):1439. doi: 10.1016/s0140-6736(85)92617-0.

Hypothyroidism Enhanced Portal Hypertension in a Patient with Alcoholic Liver Cirrhosis, Resulting in the Development of Ascites.

Intern Med. 2015;54(18):2327-31. doi: 10.2169/internalmedicine.54.4594. Epub 2015 Sep 15.

[Effect of posture on the diuretic treatment of decompensated cirrhosis and heart failure].

Ugeskr Laeger. 1989 Jan 2;151(1):13-5.

[Triamterene in diuretic therapy of cirrhogenic ascites. Modifications of water-saline metabolism induced by its administration alone and in combination with fluprednisolone, methopyrone, mercaptomerine and benzothiazides].[氨苯蝶啶在肝硬化腹水利尿治疗中的应用。单独给药及其与氟氢泼尼松、甲吡酮、巯基汞林和苯并噻嗪类联合应用对水盐代谢的影响]

Minerva Med. 1963 Oct 10;54(81 Suppl):3024-7.

Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.奥曲肽用于肝硬化乳糜性腹水的门诊治疗：一例报告

Dig Liver Dis. 2006 Feb;38(2):138-42. doi: 10.1016/j.dld.2005.05.013. Epub 2006 Jan 4.

[Triamterene in the treatment of liver cirrhosis with ascites].氨苯蝶啶治疗肝硬化腹水

Rev Clin Esp. 1972 Dec 31;127(6):1101-8.

Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.氨氯吡咪（MK-870），一种新型抗利钾性利尿剂。与其他抗利钾性利尿剂在肝病和腹水患者中的比较。

Gastroenterology. 1970 Dec;59(6):833-41.

本文引用的文献

Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.速尿与螺内酯治疗非氮质血症性肝硬化腹水疗效的随机对照研究。利尿反应与肾素-醛固酮系统活性之间的关系。

Gastroenterology. 1983 May;84(5 Pt 1):961-8.

Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients.肝硬化患者心输出量与血管阻力之间的相互关系作为有效动脉血容量的决定因素

Kidney Int. 1985 Aug;28(2):206-11. doi: 10.1038/ki.1985.142.

Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.慢性肝病腹水患者的快速利尿：外周水肿的重要性。

Gastroenterology. 1986 Jun;90(6):1827-33. doi: 10.1016/0016-5085(86)90249-0.

Salt or no salt in the treatment of cirrhotic ascites: a randomised study.肝硬化腹水治疗中使用或不使用盐：一项随机研究。

Gut. 1986 Jun;27(6):705-9. doi: 10.1136/gut.27.6.705.

Pathophysiology of ascites and functional renal failure in cirrhosis.肝硬化腹水及功能性肾衰竭的病理生理学

J Hepatol. 1988 Apr;6(2):239-57. doi: 10.1016/s0168-8278(88)80038-2.

Response to dopamine hydrochloride in the hepatorenal syndrome.

Arch Intern Med. 1975 Jul;135(7):964-71.

Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites.高剂量螺内酯治疗慢性肝病伴相对难治性腹水患者的疗效

Am J Dig Dis. 1978 Nov;23(11):1025-30. doi: 10.1007/BF01263103.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验